09/28/2015 - 2:24pm

As a result of the $8.05 billion acquisition, Endo has adjusted its guidance for FY2015.

09/28/2015 - 12:31pm

Dr. Reddy's is the latest company to introduce a generic version of AstraZeneca’s Nexium capsules. 

09/28/2015 - 12:03pm

PhRMA's next leader hails from the Advanced Medical Technology Association, where he was president and CEO for more than 10 years. 

09/28/2015 - 11:42am

Mylan’s latest generic, recently approved by the Food and Drug Administration, is intended to treat schizophrenia and schizoaffective disorder.

09/25/2015 - 3:53pm

The National Association of Chain Drug Stores on Friday released a letter to the editor in response to a Sept. 5 article in The Washington Post about efforts to improve medication adherence through research and patient-focused strategies.

09/25/2015 - 3:16pm

The Food and Drug Administration on Friday approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar control in adults with diabetes mellitus. Both Tresiba and Ryzodeg are manufactured by Novo Nordisk.

09/25/2015 - 2:49pm

In the latest on the Mylan bid for Perrigo, Mylan on Thursday released a statement about the Perrigo lawsuit filed in Israel on Thursday.

09/25/2015 - 2:19pm

Learning together with other health professionals might become more mainstream for pharmacists, according to a report published Friday by the International Pharmaceutical Federation Education Initiative.

09/25/2015 - 11:18am

Teva Pharmaceutical on Friday announced that it entered into a definitive agreement to acquire Gecko Health Innovations, which focuses on developing software and product solutions to aid in compliance and adherence improvement in the management of respiratory diseases.